Selective opioid receptor agonist and antagonist displacement of [ 3 H]naloxone binding in amphibian brain

By Newman L.C.   Wallace D.R.   Stevens C.W.  

European Journal of Pharmacology, Vol. 397, Iss. 2, 2000-06 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite

Pharmacology of JB-9315, A New Selective Histamine H 2 -Receptor Antagonist

By Palacios B.   Montero M.J.   Sevilla M.A.   San Roman L.  

General Pharmacology, Vol. 30, Iss. 2, 1998-02 ,pp. : 181-189

Elsevier

Access to resources Recommend Favorite

Effects of a histamine H 2 receptor agonist and antagonist on restraint-induced antinociception in female mice

By Chak-Lam W.  

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist: Receptor Selectivity and in Vitro Antihistaminic Activity

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustin   Orjales Aurelio  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite

Characterisation of the specific binding of the histamine H 3 receptor antagonist radioligand [ 3 H]GR168320

By Brown J.D.   O'Shaughnessy C.T.   Kilpatrick G.J.   Scopes D.I.C.   Beswick P.   Clitherow J.W.   Barnes J.C.  

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite